CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Blueprint Medicines Corp  (BPMC)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Blueprint Medicines's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

BPMC Gross Margin (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Revenue Change -16.63 % -14.82 % - 79.8 % 162.93 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 97 # 576 # 584 # 0 # 0
Seq. Revenue Change 0.86 % -24.07 % 24.85 % -12.81 % 3.05 %
Seq. Gross Profit Change - - - - -


Commenting Second Quarter 2017 Gross Margin
Blueprint Medicines has managed to improve its Revenue sequentially to $6 millions by 0.86 % faster than Gross Profit increase of 0.86 % to $6 millions, this led to contraction in Gross Margin to 100 %, a new company low.

Observing second quarter 2017 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Gross Margin. While overall Gross Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Gross Margin
BPMC's Gross Margin second quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 16
Overall # 97

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Jun 30 2017)  

You need to upgrade your Flash Player


Financial Statements
Blueprint Medicines's (Jun 30 2017) Gross Profit $ 6 BPMC's Income Statement
Blueprint Medicines's (Jun 30 2016) Gross Profit $ 7 Quarterly BPMC's Growth
BPMC's Profits by Division See BPMC's Profits by Segment

Other Gross Margin Profitability Ratios
BPMC's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
BPMC's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for BPMC's Competitors
Gross Margin Profit Margin for Blueprint Medicines's Suppliers
Gross Margin Profit Margin for BPMC's Customers

You may also want to know
BPMC's Annual Growth Rates BPMC's Profitability Ratios BPMC's Asset Turnover Ratio BPMC's Dividend Growth
BPMC's Roe BPMC's Valuation Ratios BPMC's Financial Strength Ratios BPMC's Gross Profit Growth
BPMC's Roa BPMC's Inventory Turnover Ratio BPMC's Growth Rates BPMC's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Jun 30 2017, within Major Pharmaceutical Preparations Industry Gross MarginJun 30 2017 MRQ Gross ProfitJun 30 2017 MRQ Revenue
Endocyte Inc  100.00 %$ 0.013 $ 0.013 
Dynavax Technologies Corp  100.00 %$ 0.105 $ 0.105 
Progenics Pharmaceuticals Inc  100.00 %$ 2.765 $ 2.765 
Ophthotech Corp.  100.00 %$ 1.661 $ 1.661 
Onconova Therapeutics, Inc.  100.00 %$ 0.324 $ 0.324 
Epizyme, Inc.  100.00 %$ 10.000 $ 10.000 
Enanta Pharmaceuticals Inc  100.00 %$ 7.511 $ 7.511 
Dicerna Pharmaceuticals Inc  100.00 %$ 0.252 $ 0.252 
Dermira, Inc.  100.00 %$ 1.066 $ 1.066 
Concert Pharmaceuticals, Inc.  100.00 %$ 0.015 $ 0.015 
Abeona Therapeutics Inc.  100.00 %$ 0.217 $ 0.217 
Corbus Pharmaceuticals Holdings, Inc.  100.00 %$ 0.350 $ 0.350 
Paratek Pharmaceuticals, Inc.  100.00 %$ 7.514 $ 7.514 
Prothena Corp Plc  100.00 %$ 26.812 $ 26.812 
Cytokinetics Inc  100.00 %$ 3.053 $ 3.053 
Evoke Pharma Inc  100.00 %$ 1.262 $ 1.262 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.148 $ 0.148 
Seres Therapeutics, Inc.  100.00 %$ 3.014 $ 3.014 
Macrogenics Inc  100.00 %$ 1.666 $ 1.666 
Karyopharm Therapeutics Inc.  100.00 %$ 0.003 $ 0.003 
Jazz Pharmaceuticals Plc  100.00 %$ 394.386 $ 394.386 
Intra-cellular Therapies, Inc.  100.00 %$ 0.115 $ 0.115 
Ionis Pharmaceuticals Inc  100.00 %$ 104.152 $ 104.152 
Immunogen Inc  100.00 %$ 39.020 $ 39.020 
Nabriva Therapeutics Plc  100.00 %$ 1.051 $ 1.051 
Oncomed Pharmaceuticals Inc  100.00 %$ 6.195 $ 6.195 
Fibrogen Inc  100.00 %$ 28.997 $ 28.997 
Five Prime Therapeutics Inc  100.00 %$ 7.822 $ 7.822 
Novan, Inc.  100.00 %$ 0.669 $ 0.669 
Heat Biologics, Inc.  100.00 %$ 0.411 $ 0.411 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
EWLU's Profile
Stock Price
EWLU's Financials
EWLU's Expectations
Business Description
Fundamentals
Charts & Quotes
EWLU's News
Suppliers
EWLU's Competitors
Customers & Markets
Economic Indicators
EWLU's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com